株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のスペクトラルCT市場:2025年までの予測

Global Spectral Computed Tomography (CT) Market Research Report Forecast to 2025

発行 Market Research Future 商品コード 918823
出版日 ページ情報 英文 72 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.19円で換算しております。
Back to Top
世界のスペクトラルCT市場:2025年までの予測 Global Spectral Computed Tomography (CT) Market Research Report Forecast to 2025
出版日: 2019年11月30日 ページ情報: 英文 72 Pages
概要

世界のスペクトラルCT市場は、2025年までの間に5.8%のCAGRで成長する見通しで、2025年には9億6,960万米ドルに達すると予測されています。医療用画像装置でのクラウドテクノロジーの受け入れおよび承認の高まりによって容易になった巨大なデータの保存・共有、ヘルスケア企業 - IT企業間の合併・買収の増加などは、同市場の成長を促進する要因に挙げられます。

当レポートは世界のスペクトラルCT市場について調査しており、市場機会や課題、成長および阻害要因、用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の概要

  • 調査範囲
  • 調査目的
  • 前提条件のリスト

第3章 調査方法

  • 調査方法
  • 一次調査
  • 二次調査
  • 市場規模の推計

第4章 市場の力学

  • イントロダクション
  • 成長要因
    • 医療IT部門の支出増加
    • 診断分野における技術進歩
    • 世界における癌、神経障害、心臓病などの病気の有病率増加
    • 成長要因分析
  • 阻害要因
    • スペクトラルCTの高いコスト
    • 代替イメージング法の可用性
    • 阻害要因分析
  • 市場機会
    • 新興国における成長性

第5章 市場要因分析

  • 概要
    • 研究開発
    • 製造業
    • 流通・販売
    • 販売後の監視
  • ポーターのファイブフォース分析
    • 概要
    • サプライヤーの交渉力
    • バイヤーの交渉力
    • 新規参入の脅威
    • 代替品の脅威
    • 業界内の競争

第6章 市場分析:用途別

  • イントロダクション
  • 腫瘍
  • 循環器
  • 筋骨格系障害
  • 胃腸疾患

第7章 市場分析:エンドユーザー別

  • イントロダクション
  • 診断センター
  • 病院・診療所

第8章 市場分析:地域別

  • イントロダクション
  • 南北アメリカ
    • 北米
    • 南米
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他
  • 中東・アフリカ
    • 中東
    • アフリカ

第9章 競合情勢

  • イントロダクション

第10章 企業プロファイル

  • General Electric Company
  • Koninklijke Philips N.V.
  • MARS Bioimaging Ltd
  • Neusoft Corporation
  • Shenzhen Anke High-tech Co., Ltd
  • Siemens
  • PerkinElmer Inc.

第11章 付録

  • 参照資料
  • 関連レポート
図表

List of Tables

  • TABLE 1 LIST OF ASSUMPTIONS
  • TABLE 2 PRIMARY INTERVIEWS
  • TABLE 3 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 4 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET FOR ONCOLOGY BY, REGION 2016-2025 (USD MILLION)
  • TABLE 5 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET FOR CARDIOLOGY BY, REGION 2016-2025 (USD MILLION)
  • TABLE 6 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET FOR MUSCULOSKELETAL DISORDERS BY, REGION 2016-2025 (USD MILLION)
  • TABLE 7 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET FOR GASTROINTESTINAL DISEASES BY, REGION 2016-2025 (USD MILLION)
  • TABLE 8 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 9 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET FOR DIAGNOSTIC CENTERS BY, REGION 2016-2025 (USD MILLION)
  • TABLE 10 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET FOR HOSPITALS & CLINICS BY, REGION 2016-2025 (USD MILLION)
  • TABLE 11 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, REGION 2016-2025 (USD MILLION)
  • TABLE 12 AMERICAS: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, REGION 2016-2025 (USD MILLION)
  • TABLE 13 AMERICAS: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 14 AMERICAS: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 15 NORTH AMERICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, COUNTRY 2016-2025 (USD MILLION)
  • TABLE 16 NORTH AMERICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 17 NORTH AMERICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 18 US: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 19 US: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 20 CANADA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 21 CANADA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 22 SOUTH AMERICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 23 SOUTH AMERICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 24 EUROPE: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, COUNTRY/REGION 2016-2025 (USD MILLION)
  • TABLE 25 EUROPE: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 26 EUROPE: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 27 GERMANY: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 28 GERMANY: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 29 FRANCE: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 30 FRANCE: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 31 UK: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 32 UK: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 33 ITALY: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 34 ITALY: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 35 SPAIN: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 36 SPAIN: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 37 REST OF EUROPE: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 38 REST OF EUROPE: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 39 ASIA-PACIFIC: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY,COUNTRY/REGION 2016-2025 (USD MILLION)
  • TABLE 40 ASIA-PACIFIC: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 41 ASIA-PACIFIC: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 42 CHINA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 43 CHINA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 44 JAPAN: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 45 JAPAN: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 46 INDIA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 47 INDIA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 48 SOUTH KOREA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 49 SOUTH KOREA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 50 AUSTRALIA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 51 AUSTRALIA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 52 REST OF ASIA-PACIFIC: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 53 REST OF ASIA-PACIFIC: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 54 MIDDLE EAST & AFRICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, REGION 2016-2025 (USD MILLION)
  • TABLE 55 MIDDLE EAST & AFRICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 56 MIDDLE EAST & AFRICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 57 MIDDLE EAST: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 58 MIDDLE EAST: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 59 AFRICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2016-2025 (USD MILLION)
  • TABLE 60 AFRICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2016-2025 (USD MILLION)
  • TABLE 61 MAJOR MANUFACTURERS IN THE GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET

List of Figures

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET: STRUCTURE
  • FIGURE 3 RESEARCH PROCESS
  • FIGURE 4 TOP-DOWN AND BOTTOM-UP APPROACHES
  • FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET
  • FIGURE 6 VALUE CHAIN: GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET
  • FIGURE 8 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, APPLICATION 2018 & 2025 (USD MILLION)
  • FIGURE 9 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET BY, END USER 2018 & 2025 (USD MILLION)
  • FIGURE 10 GLOBAL SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY, REGION 2018 (%)
  • FIGURE 11 AMERICAS: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY, REGION 2018 (%)
  • FIGURE 12 NORTH AMERICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY, COUNTRY 2018 (%)
  • FIGURE 13 EUROPE: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY, COUNTRY/REGION 2018 (%)
  • FIGURE 14 ASIA-PACIFIC: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY, COUNTRY/REGION 2018 (%)
  • FIGURE 15 MIDDLE EAST & AFRICA: SPECTRAL COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY, REGION 2018 (%)
目次

Spectral Computed Tomography (CT) Market Research Report - Global Forecast till 2025

Global Spectral Computed Tomography Market: Information by Application (Oncology, Cardiology, Musculoskeletal Disorders and Gastrointestinal Diseases), End User (Diagnostic Centers and Hospitals & Clinics) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

Market Analysis

Spectral computed tomography (CT) is also known as dual-energy CT (DECT). It is an advanced form of computed tomography widely used in x-ray scanning techniques. Spectral computed tomography is an advanced medical imaging device, which helps in the differentiation and characteristics of tissues through the high quality of X-ray images. Spectral computed tomography (CT) contains two separate energy spectra which provide a brief image based on material density. The key factors responsible for driving the market growth are rising prevalence of diseases such as cancer, neurological disorders, and cardiac diseases across the globe, increasing expenditure on the healthcare IT sector, and technological advancements in the diagnostics sector. However, the high cost of spectral emission tomography and availability of alternate imaging methods is forecast to restrain growth of the market. Rising technological advancements in diagnostic imaging devices are believed to grow the market in the coming years. Computed tomography, radiography, and fluoroscopy are different forms of medical imaging devices used in x-ray scanning by hospitals. Rising adaption of IT in medical devices to enhance the quality of the product is a significant step in the medical imaging industry. Medical image management is closely associated with diagnosis services and is an essential component of the healthcare IT sector. The healthcare IT sector plays a major role in medical device industry by improving the effectiveness of products at every level of use. By secondary studies, it is found that healthcare IT spending has been grown rapidly in recent years, which is expected to lead the growth of the spectral CT market and its related services during the forecast period of 2019 to 2025. The rise in investment to improve and advance healthcare IT by global market leaders such as Siemens Healthcare, GE Healthcare, Koninklijke Philips N.V. shows the potential scope for the growth of the medical imaging industry. Growing acceptance and approval of the cloud technology in medical image devices provide easy storing and sharing of huge data. Also, increasing mergers and takeovers between healthcare and IT companies expedite market growth. Additionally, developed economies such as the US, UK, and Japan is contributing to boosting market growth by the adoption of cloud technology in medical imaging. The global spectral computed tomography market is divided into the application and end user. Based on application, the market has been segmented into oncology, cardiology, musculoskeletal disorders, and gastrointestinal diseases. Based on end user, the global spectral computed tomography market has been segmented into diagnostic centers, and hospitals & clinics. The Global Spectral Computed Tomography Market is expected to register a CAGR of 5.8% to reach USD 969.6 Million till 2025.

Market Segmentation

Global Spectral Computed Tomography Market has been segmented by Application, by end user and by region. Based on application the global spectral computed tomography market has been segmented into Oncology, Cardiology, Musculoskeletal Disorders and Gastrointestinal Diseases. By End User the market has been segmented into Diagnostic Centres and Hospitals & Clinics. Geographically, the market has been segmented into Americas including North America (US & Canada) and Latin America, Europe including Western Europe (Germany, UK, France, Italy, Spain and Rest of Western Europe) and Eastern Europe. Asia-Pacific covering China, Japan, India, Australia, South Korea and Rest of Asia-Pacific, and Middle East & Africa

Regional Analysis

Regionally, the global spectral computed tomography market is structured into Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Asia-Pacific are expected to hold the biggest share of the global spectral computed tomography market. The growth of the Asia-Pacific is attributable owing to the growing prevalence of cancer, cardiovascular diseases, and an increase in the elderly population with numerous diseases. The National Institute of Cancer Prevention and Research calculates that 2.25 million people are living with cancer in the year 2019, and each year, around 11,57,294 lakh new patients who are suffering from cancer in this region. America is projected to account for the second-largest market share during the forecast period. Factors responsible for the market growth in this region are the presence of a large number of medical device companies, ever-increasing healthcare expenditure, and innovation for medical devices to improve the quality of life. The European region stood third-largest in the year 2017 in terms of market share. Factors such as growth in the medical device industry, the presence of the developed economies, high per capita disposable income, and increased healthcare spending by consumers are driving the growth of the market in this region. Also, ever-growing partnerships among healthcare companies are likely to drive the spectral computed tomography (CT) market. For instance, in March 2018, Koninklijke Philips NV entered into a 15-year strategic partnership with ZorgSaam Hospital based in the Netherlands. In the year 2018, the Middle East & Africa is expected to expose the very least that growth in the global spectral computed tomography market due to factors such as low per capita income, and lack of adequate healthcare infrastructure support accounted for a comparatively smaller market share.

Major Players

The proposed spectators in the Global Spectral Computed Tomography Market are huge corporates, SMEs, distributors and wholesalers, Investors and trade experts, Governments, associations and industrial bodies, etc. The major companies functioning in the Global Spectral Computed Tomography Market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global Spectral Computed Tomography Market are Medical device companies, Contract research manufacturing organizations, Research & development organizations and Academic institutes. Koninklijke Philips N.V. (Amsterdam, Netherlands), New Zealand), Siemens (UK), and PerkinElmer Inc. (Waltham, Massachusetts), Shenzhen Anke High-tech Co., Ltd (China), Neusoft Corporation (China), MARS Bioimaging Ltd (Christchurch and General Electric Company (US) are some of the major players in the global spectral computed tomography market. Innovation, product development, and acquisition & mergers are some of the key strategies followed by players operating in the global spectral computed tomography market. Some of the key achievements are In March 2019, Koninklijke Philips N.V. announced the expansion of its radiology solutions portfolio with teleradiology services. Teleradiology includes the interpretation of patients' images from diagnostic imaging exams, such as X-ray exams, MR, and CT. This is in addition to the company's organic innovation initiatives designed to broaden its radiology solutions portfolio. Philips entered into a 15-year strategic partnership with ZorgSaam Hospital based in the Netherlands. As per the agreement, Philips will provide ZorgSaam with a wide range of diagnostic imaging and image-guided therapy solutions, among others in March 2018.

Table of Contents

1 Executive Summary

2 Market Introduction

  • 2.1 Scope of the Study
  • 2.2 Research Objective
  • 2.3 List of Assumptions

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Increasing Expenditure on the Healthcare IT Sector
    • 4.2.2 Technological Advancements in the Diagnostics Sector
    • 4.2.3 Growing Prevalence of Diseases such as Cancer, Neurological Disorders, and Cardiac Diseases Across the Globe
    • 4.2.4 Drivers Analysis
  • 4.3 Restraints
    • 4.3.1 High Cost of Spectral Computed Tomography
    • 4.3.2 Availability of Alternative Imaging Methods
    • 4.3.3 Restraints Analysis
  • 4.4 Opportunity
    • 4.4.1 Growth Potential in Emerging Countries

5 Market Factor Analysis

  • 5.1 Overview
    • 5.1.1 Research and Development
    • 5.1.2 Manufacturing
    • 5.1.3 Distribution and Sales
    • 5.1.4 Post-Sales Monitoring
  • 5.2 Porter's Five Forces Model
    • 5.2.1 Overview
    • 5.2.2 Bargaining Power of Suppliers
    • 5.2.3 Bargaining Power of Buyers
    • 5.2.4 Threat of New Entrants
    • 5.2.5 Threat of Substitutes
    • 5.2.6 Intensity of Rivalry

6 Global Spectral Computed Tomography (CT) Market by, Application

  • 6.1 Introduction
  • 6.2 Oncology
  • 6.3 Cardiology
  • 6.4 Musculoskeletal Disorders
  • 6.5 Gastrointestinal Diseases

7 Global Spectral Computed Tomography (CT) Market by, End User

  • 7.1 Introduction
  • 7.2 Diagnostic Centers
  • 7.3 Hospitals & Clinics

8 Global Spectral Computed Tomography (CT) Market by, Region

  • 8.1 Introduction
  • 8.2 Americas
    • 8.2.1 North America
      • 8.2.1.1 US
      • 8.2.1.2 Canada
    • 8.2.2 South America
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 France
    • 8.3.3 UK
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia-Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 South Korea
    • 8.4.5 Australia
    • 8.4.6 Rest of Asia-Pacific
  • 8.5 Middle East & Africa
    • 8.5.1 Middle East
    • 8.5.2 Africa

9 Competitive Landscape

  • 9.1 Introduction

10 Company Profiles

  • 10.1 General Electric Company
    • 10.1.1 Company Overview
    • 10.1.2 Financial Overview
    • 10.1.3 Products/Services Offered
    • 10.1.4 Key Developments
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Strategies
  • 10.2 Koninklijke Philips N.V.
    • 10.2.1 Company Overview
    • 10.2.2 Financial Overview
    • 10.2.3 Products/Services Offered
    • 10.2.4 Key Developments
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Strategies
  • 10.3 MARS Bioimaging Ltd
    • 10.3.1 Company Overview
    • 10.3.2 Financial Overview
    • 10.3.3 Products/Services Offered
    • 10.3.4 Key Developments
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Strategies
  • 10.4 Neusoft Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Financial Overview
    • 10.4.3 Products/Services Offered
    • 10.4.4 Key Developments
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Strategies
  • 10.5 Shenzhen Anke High-tech Co., Ltd
    • 10.5.1 Company Overview
    • 10.5.2 Financial Overview
    • 10.5.3 Products/Services Offered
    • 10.5.4 Key Developments
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Strategies
  • 10.6 Siemens
    • 10.6.1 Company Overview
    • 10.6.2 Financial Overview
    • 10.6.3 Products/Services Offered
    • 10.6.4 Key Developments
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Strategies
  • 10.7 PerkinElmer Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Financial Overview
    • 10.7.3 Products/Services Offered
    • 10.7.4 Key Developments
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Strategies

11 Appendix

References

Related Reports

Back to Top